Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
We've long known that DNA is important, because it contains the code for building the proteins that make up our bodies. However, a lot of our DNA – most of it, in fact – does not contain instructions for making proteins.
This non-coding DNA was at one point labelled "junk DNA," as it wasn't clear what purpose it had if it wasn't for storing the code for proteins.
Scientists have been discovering that the non-coding DNA is in fact far from "junk," and is important in the regulation of many of our bodies' processes.
A recent study published in
Cell by Dr.
Hansen He helps underline this point, as changing a single nucleotide (or "letter") in the DNA code led to patients being at risk for a more aggressive form of prostate cancer.
The team used big data approaches and experimental techniques to identify what changed when a specific region of non-coding DNA called risk-associated SNP rs11672691 locus was altered by one nucleotide.
The small change in a seemingly unimportant region of DNA led to a cascade of changes in the cell, like the proverbial flap of a butterfly's wings that changed the course of a hurricane. In this case, the genetic change ultimately affected a set of other genes that are related to prostate cancer cell growth and spread.
This work helps clarify the importance of some single nucleotide changes. Also, it may allow clinicians to provide patients with the altered SNP rs11672691 DNA with more appropriate treatments and additional vigilance against relapse of their prostate cancer.
This work was supported by the Natural Sciences and Engineering Research Council, the Canadian Institutes of Health Research, the Movember Foundation/Prostate Cancer Canada, the US Department of Defense, The Terry Fox Research Institute, the Ontario Ministry of Research, Innovation, and Science, and The Princess Margaret Cancer Foundation.